Bonk (NASDAQ:BNKK) Upgraded at Wall Street Zen

Wall Street Zen upgraded shares of Bonk (NASDAQ:BNKK) to a sell rating in a report published on Saturday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Bonk in a research report on Monday, December 8th. One research analyst has rated the stock with a Sell rating, According to MarketBeat.com, Bonk presently has a consensus rating of “Sell”.

Bonk Price Performance

Shares of NASDAQ:BNKK opened at $3.80 on Friday. Bonk has a 52 week low of $3.05 and a 52 week high of $46.90. The firm has a market capitalization of $19.99 million, a price-to-earnings ratio of -17.27 and a beta of 1.82.

Bonk (NASDAQ:BNKK) last posted its quarterly earnings data on Wednesday, November 19th. The company reported ($3.85) earnings per share (EPS) for the quarter. The firm had revenue of $1.51 million during the quarter.

Bonk Company Profile

Safety Shot, Inc, a wellness and functional beverage company, engages in the research and development of over-the-counter products and intellectual property. Its products pipeline includes Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women’s sexual wellness; NoStingz, a jellyfish sting prevention sunscreen; and JW-110 for the treatment of atopic dermatitis/eczema.